The use of CXCR2 antagonist SB225002 in vitro has an apoptotic effect on B-ALL and T-ALL cells [96], although this effect may be due to SB225002’s direct action on β-tubulin [96,97,98]. The gene discussed is CXCR2; the disease is acute lymphoblastic leukemia.